Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
February 14, 2019
Achaogen Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address ...
February 14, 2019
Paratek Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference
BOSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today ...
February 14, 2019
Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update
DUBLIN, Ireland, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a clinical-stage neuroscience company, today reported financial results for the fourth quarter and ...
February 14, 2019
Anchiano Therapeutics Announces Closing of $30.5 Million Initial Public Offering
CAMBRIDGE, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”) today announced that it has closed its initial public ...
February 13, 2019
Calabasas Behavioral Health and BrainsWay Host “After the Smoke Clears
CALABASAS, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Calabasas Behavioral Health, a leading mental health service provider in Southern California, announced today that it is ...
February 13, 2019
STRATA Skin Sciences to Participate in the BTIG MedTech, Life Science and Diagnostic Tools Conference
HORSHAM, Pa., Feb. 13, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
February 13, 2019
Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering
NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its ...
February 13, 2019
Y-mAbs Therapeutics to Present at PEGS Boston
NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (YMAB) a late-stage clinical biopharmaceutical company focused on the development ...
February 13, 2019
Onxeo to Present Five Preclinical Studies Highlighting AsiDNA™ Unique Profile and its clinical potential in Oncology at 2019 American Association for Cancer Research Annual Meeting
Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor ...
February 13, 2019
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results on February 27, 2019
BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, ...
February 13, 2019
AIT Therapeutics Reports Financial Results for Fiscal Third Quarter 2019
GARDEN CITY, N.Y. and REHOVOT, Israel, Feb. 13, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on ...
February 13, 2019
Urovant Sciences Reports Financial Results for the Third Fiscal Quarter Ended December 31, 2018
BASEL, Switzerland & IRVINE, Calif.--(BUSINESS WIRE)--Urovant Sciences Ltd. (UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today reported ...
February 12, 2019
Kamada Reports Financial Results for Fourth Quarter and Fiscal Year 2018
REHOVOT, Israel, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA.TA), a plasma-derived protein therapeutics company, today announced financial results for the three and ...
February 12, 2019
Check-Cap Announces Institutional Review Board Approval to Initiate U.S. Pilot Study of C-Scan®
ISFIYA, Israel, Feb. 12, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (CHEK) (CHEKW), (CHEKZ), a clinical-stage medical diagnostics company advancing the development of ...
February 12, 2019
Palatin Technologies, Inc. Reports Second Fiscal Quarter 2019 Results and Provides Corporate Update
CRANBURY, N.J., Feb. 12, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...
February 12, 2019
Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan in Patients with Decompensated NASH Cirrhosis
SAN DIEGO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) today announced the completion of enrollment in ENCORE-LF, a Phase 2b clinical trial ...
February 12, 2019
ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors
RAMSEY, N.J. and BOCA RATON, Fla., Feb. 12, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
February 12, 2019
Genocea Announces Private Placement Financing of Up to $39 Million
CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it has entered ...
February 12, 2019
Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings Corporation
NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential clinical-stage ...
February 12, 2019
Anchiano Therapeutics Announces Pricing of $30.5 Million Initial Public Offering
CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”) today announced that it has priced its initial public ...
Page 13 of 138